Hanan Ibrahim Sheikh Ibrahim, MD | |
1415 Portland Ave Ste 200, Rochester, NY 14621-3022 | |
(585) 922-0390 | |
(585) 922-0395 |
Full Name | Hanan Ibrahim Sheikh Ibrahim |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 1415 Portland Ave Ste 200, Rochester, New York |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003426222 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RG0300X | Internal Medicine - Geriatric Medicine | 304955 (New York) | Primary |
Mailing Address | Practice Location Address |
---|---|
Hanan Ibrahim Sheikh Ibrahim, MD 100 Kings Hwy S, Rochester, NY 14617-5504 Ph: (585) 922-0390 | Hanan Ibrahim Sheikh Ibrahim, MD 1415 Portland Ave Ste 200, Rochester, NY 14621-3022 Ph: (585) 922-0390 |
News Archive
Gov. Pat Quinn continued his ribbon-cutting spree today, announcing the state will spend $30.5 million to build and renovate 14 health centers across the state that provide care for low-income patients.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today reported its unaudited financial results for the second quarter ended June 30, 2010.
An advisory committee recommended today that the Food and Drug Administration (FDA) approve QAB149 (indacaterol) 75 mcg in the US as a once-daily long-term maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.
A new microarray-based tool, called VaginArray, offers the potential to provide a fast, reliable and low-cost assessment of vaginal health and diagnoses of infections. The research is published ahead of print March 2, in Antimicrobial Agents and Chemotherapy, a journal of the American Society for Microbiology.
Biogen Idec and Swedish Orphan Biovitrum today announced that the first patient has been dosed with the companies' long-lasting recombinant Factor VIII Fc fusion protein (rFVIIIFc) in a global registrational clinical trial. The study, called A-LONG, is an open-label, multicenter, Phase 2/3 study designed to evaluate the safety, pharmacokinetics and efficacy of rFVIIIFc in previously-treated hemophilia A patients.
› Verified 1 days ago
Amy Bodrog, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 1425 Portland Ave, Rochester, NY 14621 Phone: 585-922-4020 Fax: 585-922-4622 | |
Natalia Golub, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 30 Hagen Dr Ste 320, Rochester, NY 14625 Phone: 585-922-1900 | |
Numra Aslam Bajwa, MD Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 1425 Portland Ave, Rochester, NY 14621 Phone: 585-922-5067 Fax: 716-862-1871 | |
Dr. Prakash Upreti, MD Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 1425 Portland Ave, Rochester, NY 14621 Phone: 295-029-8769 | |
William M Valenti, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 259 Monroe Avenue, Rochester, NY 14607 Phone: 585-545-7200 Fax: 585-244-6456 | |
Ms. Terri Winter, N.P. Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 250 Crittenden Blvd, Box 617, Rochester, NY 14642 Phone: 585-275-2662 Fax: 585-276-0149 |